/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for.
Aadi Bioscience, Inc. (NASDAQ:AADI) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Aadi Bioscience (AADI) Reports Interim Results from PRECISION1 Trial of nab-Sirolimus streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Aadi Bioscience, Inc. (NASDAQ:AADI) Q2 2023 Earnings Call Transcript August 9, 2023 Aadi Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.64. Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience, Incorporated Second Quarter 2023 Earnings Call. At this time all participants are in a […]